Sign inGet started

KANTOFF AARON

Insider CIK 1862734 · AVTX Director · TRML Director · CNTA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVTX Avalo Therapeutics, Inc. A Award deriv2026-06-022026-06-0420,100— $020,100SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2026-03-282026-03-313,166— $03,167SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2026-03-282026-03-313,166— $06,333SEC↗
TRML Tourmaline Bio, Inc. D To issuer deriv2025-10-282025-10-2810,000— $00SEC↗
TRML Tourmaline Bio, Inc. D To issuer deriv2025-10-282025-10-2816,800— $00SEC↗
TRML Tourmaline Bio, Inc. U Tender2025-10-282025-10-2888,281— $00SEC↗
TRML Tourmaline Bio, Inc. G Gift2025-10-242025-10-245,000— $088,281SEC↗
TRML Tourmaline Bio, Inc. M Exercise deriv2025-09-052025-09-0937,890— $00SEC↗
TRML Tourmaline Bio, Inc. M Exercise deriv2025-09-052025-09-0910,000— $00SEC↗
TRML Tourmaline Bio, Inc. M Exercise2025-09-052025-09-0910,000$9.46 $94.6K93,281SEC↗
TRML Tourmaline Bio, Inc. M Exercise2025-09-052025-09-0937,890$0.13 $4.9K83,281SEC↗
AVTX Avalo Therapeutics, Inc. A Award deriv2025-06-172025-06-1820,100— $020,100SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2025-06-042025-06-0616,800— $016,800SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise deriv2025-03-282025-04-013,167— $06,333SEC↗
AVTX Avalo Therapeutics, Inc. M Exercise2025-03-282025-04-013,167— $03,167SEC↗
AVTX Avalo Therapeutics, Inc. A Award deriv2024-08-132024-08-1424,600— $024,600SEC↗
AVTX Avalo Therapeutics, Inc. A Award deriv2024-08-132024-08-149,500— $09,500SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2024-06-052024-06-0710,000— $010,000SEC↗
TRML Tourmaline Bio, Inc. P Buy2023-10-242023-10-267,500$11.86 $89.0K45,391SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2023-10-232023-10-2310,000— $010,000SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2023-10-192023-10-2337,890— $037,890SEC↗
TRML Tourmaline Bio, Inc. A Award2023-10-192023-10-2337,891— $037,891SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-11-182021-11-1810,000$11.99 $119.9K60,000SEC↗